Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer

Sana Kalave1, Namita Hegde1, Kapil Juvale1

  • 1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle [W], Mumbai, India.

Insights

Multidrug resistance (MDR) in cancer hinders treatment. This review explores nanoformulations as a promising strategy to overcome MDR by targeting tumors, potentially improving patient outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Delivery

Background:

  • Cancer remains a leading global cause of death, with chemotherapy and radiation therapy as primary treatments.
  • Multidrug resistance (MDR) significantly impedes cancer treatment efficacy and contributes to cancer relapse.
  • Existing MDR reversing agents show limited clinical benefits, necessitating novel therapeutic strategies.

Approach:

  • This review focuses on nanoformulations as a novel approach to overcome or bypass MDR in cancer.
  • Nanoformulations offer selective accumulation in tumor tissues, enhancing therapeutic outcomes for MDR cancer patients.
  • Various nano-formulations, including carbon nanotubes, liposomes, and dendrimers, are discussed for their potential against MDR.

Key Points:

  • Nanoformulations represent an attractive strategy for overcoming multidrug resistance in cancer.
  • Selective tumor targeting by nanosized materials improves clinical outcomes in MDR cancer.
  • Diverse nano-formulation types (e.g., carbon nanotubes, liposomes, dendrimers) are evaluated for MDR treatment.

Conclusions:

  • Nano-based approaches offer a promising avenue for treating multidrug-resistant cancers.
  • Further research into nanotechnology-based strategies can significantly advance MDR cancer therapy.
  • This review provides an overview to aid researchers in exploring nanotechnology applications for MDR cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K